4.7 Article

Histone recognition and nuclear receptor co-activator functions of Drosophila Cara Mitad, a homolog of the N-terminal portion of mammalian MLL2 and MLL3

期刊

DEVELOPMENT
卷 139, 期 11, 页码 1997-2008

出版社

COMPANY OF BIOLOGISTS LTD
DOI: 10.1242/dev.076687

关键词

Drosophila; Co-activator; Histone; Hormone; Patterning

资金

  1. National Institutes of Health [1PO1-CA105049-01]
  2. National Science Foundation [MCB0818620, MCB1122001]
  3. Direct For Biological Sciences [0818620] Funding Source: National Science Foundation
  4. Direct For Biological Sciences
  5. Div Of Molecular and Cellular Bioscience [1122001] Funding Source: National Science Foundation
  6. Div Of Molecular and Cellular Bioscience [0818620] Funding Source: National Science Foundation

向作者/读者索取更多资源

MLL2 and MLL3 histone lysine methyltransferases are conserved components of COMPASS-like co-activator complexes. In vertebrates, the paralogous MLL2 and MLL3 contain multiple domains required for epigenetic reading and writing of the histone code involved in hormone-stimulated gene programming, including receptor-binding motifs, SET methyltransferase, HMG and PHD domains. The genes encoding MLL2 and MLL3 arose from a common ancestor. Phylogenetic analyses reveal that the ancestral gene underwent a fission event in some Brachycera dipterans, including Drosophila species, creating two independent genes corresponding to the N- and C-terminal portions. In Drosophila, the C-terminal SET domain is encoded by trithorax-related (trr), which is required for hormone-dependent gene activation. We identified the cara mitad (cmi) gene, which encodes the previously undiscovered N-terminal region consisting of PHD and HMG domains and receptor-binding motifs. The cmi gene is essential and its functions are dosage sensitive. CMI associates with TRR, as well as the EcR-USP receptor, and is required for hormone-dependent transcription. Unexpectedly, although the CMI and MLL2 PHDf3 domains could bind histone H3, neither showed preference for trimethylated lysine 4. Genetic tests reveal that cmi is required for proper global trimethylation of H3K4 and that hormone-stimulated transcription requires chromatin binding by CMI, methylation of H3K4 by TRR and demethylation of H3K27 by the demethylase UTX. The evolutionary split of MLL2 into two distinct genes in Drosophila provides important insight into distinct epigenetic functions of conserved readers and writers of the histone code.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Pathology

Eosinophilic Renal Cell Tumors With a TSC and MTOR Gene Mutations Are Morphologically and Immunohistochemically Heterogenous Clinicopathologic and Molecular Study

Melissa Tjota, Heather Chen, Megan Parilla, Pankhuri Wanjari, Jeremy Segal, Tatjana Antic

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)

Review Cell Biology

Beyond the Variants: Mutational Patterns in Next-Generation Sequencing Data for Cancer Precision Medicine

Megan Parilla, Lauren L. Ritterhouse

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Article Pathology

Uterine Tumor Resembling Ovarian Sex Cord Stromal Tumor (UTROSCT) A Series of 3 Cases With Extensive Rhabdoid Differentiation, Malignant Behavior, and ESR1-NCOA2 Fusions

Jennifer A. Bennett, Ricardo R. Lastra, Julieta E. Barroeta, Megan Parilla, Filippo Galbo, Pankhuri Wanjari, Robert H. Young, Thomas Krausz, Esther Oliva

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)

Editorial Material Hematology

Red cell morphology in sickle cell disease

Megan Parilla, Sandeep Gurbuxani

Article Pathology

A Tale of 2 Morphologies: Diagnostic Pitfalls in TFEB-Associated Renal Cell Carcinomas, Including a Novel NEAT1-TFEB Fusion

Aarti E. Sharma, Megan Parilla, Pankhuri Wanjari, Jeremy P. Segal, Tatjana Antic

Summary: Translocation-associated renal cell carcinomas have diverse morphologies and require a high degree of suspicion for accurate diagnosis. Two cases with distinct appearances were found to harbor unique pathogenic rearrangements through RNA sequencing techniques.

INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2021)

Article Pathology

BAP1-Mutated Clear Cell Renal Cell Carcinoma A Clinicopathologic Characterization of 14 Molecularly Confirmed Tumors

Alexander J. Gallan, Megan Parilla, Jeremy Segal, Lauren Ritterhouse, Tatjana Antic

Summary: The study identifies the pathological features of BAP1-mutated CCRCC, which exhibit overlapping morphological characteristics with other subtypes of renal cell carcinoma and specific immunohistochemical patterns. BAP1-mutated CCRCCs are often aggressive, with a high likelihood of invasion and metastasis.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2021)

Review Gastroenterology & Hepatology

Benign vs malignant pancreatic lesions: Molecular insights to an ongoing debate

Mahmoud Aldyab, Tony El Jabbour, Megan Parilla, Hwajeong Lee

Summary: Various benign conditions can mimic pancreatic ductal adenocarcinoma (PDAC) and thorough histologic examination, immunohistochemical staining, and molecular markers are crucial for accurate diagnosis. Specific immunohistochemical markers, such as SMAD4, can aid in distinguishing PDAC. Mutations, especially in the KRAS oncogene, along with additional mutations in tumor suppressor genes like CDKN2A, TP53, and SMAD4, play a role in neoplastic progression and prognosis assessment in PDAC.

WORLD JOURNAL OF GASTROINTESTINAL SURGERY (2021)

Article Pathology

Recurrent Loss of Heterozygosity in Pancreatic Neuroendocrine Tumors

Megan Parilla, David Chapel, Jaclyn F. Hechtman, Pankhuri Wanjari, Tony El Jabbour, Aarti Sharma, Lauren Ritterhouse, Jeremy Segal, Chad Vanderbilt, David S. Klimstra, Namrata Setia, Laura Tang

Summary: Chromosomal aneuploidies are prognostic markers for various tumor types, including pancreatic neuroendocrine tumors. This study identified three clinically relevant chromosomal subgroups within pancreatic neuroendocrine tumors, namely indolent subgroup, aggressive subgroup, and heterogeneous third group.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2022)

Article Oncology

ATM Germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic Implications

Tony El Jabbour, Maksym Misyura, Darren Cowzer, Michal Zimmermann, Victoria Rimkunas, Antonio Marra, Fatemeh Derakhshan, Pier Selenica, Megan Parilla, Jeremy S. Setton, Ozge Ceyhan-Birsoy, Yelena Kemel, Amanda Catchings, Megha Ranganathan, Geoffrey Y. Ku, Yelena Y. Janjigian, Michael Zinda, Maria Koehler, Zsofia Stadler, Jinru Shia, Jorge S. Reis-Filho, Diana Mandelker

Summary: The study identified the crucial role of ATM gene mutations in the development of GEJ adenocarcinoma and suggested that genetic testing may aid in prognostication and treatment decision-making.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2022)

Article Health Care Sciences & Services

Toward a More Just System of Care in Molecular Pathology

Cullen M. Lilley, Minerve Delille, Kamran M. Mirza, Megan Parilla

Summary: American health care policy needs critical assessment to understand its role in addressing health disparities in molecular genetic testing. To address these disparities, it is necessary to reduce healthcare costs, rebalance regional disparities, encourage physician engagement, reduce data biases, and earn patients' trust.

MILBANK QUARTERLY (2022)

Article Pathology

Triple-Negative Primary Myelofibrosis: A Bone Marrow Pathology Group Study

Yahya A. Al-Ghamdi, Jonathan Lake, Adam Bagg, Beenu Thakral, Sa A. Wang, Carlos Bueso-Ramos, Lucia Masarova, Srdan Verstovsek, Heesun J. Rogers, Eric D. Hsi, Jonathon H. Gralewski, Devon Chabot-Richards, Tracy I. George, Anton Rets, Robert P. Hasserjian, Olga K. Weinberg, Megan Parilla, Daniel A. Arber, Osvaldo Padilla, Attilio Orazi, Wayne Tam

Summary: This study compared the pathological and genetic characteristics between triple-negative primary myelofibrosis (TN-PMF) and PMF with canonical driver mutations (DM-PMF). The results showed that TN-PMF patients were more likely to have thrombocytopenia and less likely to have organomegaly. The bone marrow of TN-PMF patients showed fewer granulocytic elements and more frequent dyserythropoiesis. Cytogenetic analysis revealed a higher incidence of trisomy 8, and targeted next-generation sequencing identified a lower frequency of ASXL1 mutations but enrichment of ASXL1/SRSF2 comutations. These findings suggest that TN-PMF may be pathogenetically different from DM-PMF, with potential prognostic implications.

MODERN PATHOLOGY (2023)

Review Pathology

An update on genetic aberrations in T-cell neoplasms

Megan Parilla, Andres E. Quesada, L. Jeffrey Medeiros, Beenu Thakral

Summary: T-cell neoplasms, comprising 10-15% of all lymphoid neoplasms, have been less understood compared to B-cell neoplasms due to their rarity. However, recent advancements in understanding T-cell differentiation based on gene expression and mutation profiling have shed light on their pathogenesis. This knowledge has been used to refine diagnostic criteria and improve prognostication and identification of therapeutic targets, leading to potential improved outcomes for patients.

PATHOLOGY (2023)

Article Anatomy & Morphology

Epigenetic Dysregulation of 5-hydroxymethylcytosine in Well-Differentiated Pancreatic Neuroendocrine Tumors

Aarti E. Sharma, Andrea Olivas, Megan Parilla, Lindsay Yassan, Hanlin Wang, Sharon S. Zhang, Christopher Weber, Xavier M. Keutgen, John Hart, Thomas Krausz, Namrata Setia

Summary: The loss of expression of 5-hydroxymethylcytosine (5-hmC) is associated with aggressive behavior in pancreatic neuroendocrine tumors (PanNETs). Factors such as lymph node metastasis, lymphovascular invasion, and lack of 5-hmC expression can predict the risk of distant metastasis in PanNETs. In addition, there is intratumoral heterogeneity in the expression of 5-hmC.

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2022)

Article Pathology

Follicular Thyroid Neoplasms Comparison of Clinicopathologic and Molecular Features of Atypical Adenomas and Follicular Thyroid Carcinomas

Vincent Cracolici, Lauren L. Ritterhouse, Jeremy P. Segal, Rutika Puranik, Pankhuri Wanjari, Sabah Kadri, Megan Parilla, Nicole A. Cipriani

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)

Article Pathology

An Evaluation of CD61 Immunohistochemistry in Identification of Vascular Invasion in Follicular Thyroid Neoplasms

Vincent Cracolici, Megan Parilla, Kammi J. Henriksen, Nicole A. Cipriani

HEAD & NECK PATHOLOGY (2020)

暂无数据